Becton, Dickinson and Company ($BDX) Insider Trading & Smart Money Activity
Becton, Dickinson and Company ($BDX) has 3 insider trades, 3 congress trades, 95 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($185.65K), net -$185.65K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$185.65K
- Congress trades (12 mo)
- 3
- 13F moves on file
- 95
- Analyst ratings on file
- 1
BDX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 2 / 3 |
| Q2 2026 | 0 | 2 · $171.69K | 0 / 2 | 15 / 70 |
| Q3 2026 | 0 | 1 · $13.96K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 1 / 4 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All BDX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | TCV Trust & Wealth Management | Reduced | -1.69K sh | $307.70K | — | ||||||
| 13F | Forbes J M | Reduced | -31.50K sh | $877.28K | — | ||||||
| 13F | Guyasuta Investment Advisors | Reduced | -4.46K sh | $27.60M | — | ||||||
| 13F | Traphagen Investment Advisors | Reduced | -2.25K sh | $223.80K | — | ||||||
| 13F | Patriot Financial Group Insurance Agency | Added | +8.15K sh | $5.58M | — | ||||||
| Analyst | Barclays | Reiterates to Underweight | PT $165 | +4.8% | — | ||||||
| Insider | Feld MichaelEVP, Chief Revenue Officer | Sell (Open-market sale) 10b5-1 | 76 sh | $13.96K | -1.7% | — | |||||
| Insider | Michael FeldEVP, Chief Revenue Officer | Sell (Open-market sale) 10b5-1 | 75 sh | $11.46K | -0.2% | +1.9% | Read | ||||
| Insider | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Sell (Open-market sale) 10b5-1 | 1.10K sh | $160.23K | +3.5% | +5.8% | Read | ||||
| Congress | Thomas Kean | Sale | $1,001 - $15,000 | +1.5% | -3.1% | Read | |||||
| Congress | Thomas H. Kean Jr. | Sale | $1,001 - $15,000 | +1.5% | -3.1% | Read | |||||
| 13F | Wellington Management Group | Reduced | -125.14K sh | $1.03B | +2.9% | +2.1% | — | ||||
| 13F | Wellington Management Group | Reduced | -125.14K sh | $974.75M | +2.9% | +2.1% | — | ||||
| 13F | T. Rowe Price Investment Management | Reduced | -8.60M sh | $1.47B | +2.9% | +2.1% | — | ||||
| 13F | T. Rowe Price Investment Management | Reduced | -8.60M sh | $1.43B | +2.9% | +2.1% | — | ||||
| 13F | State Street | Reduced | -3.97M sh | $2.15B | +2.9% | +2.1% | — | ||||
| 13F | State Street | Reduced | -3.97M sh | $2.04B | +2.9% | +2.1% | — | ||||
| 13F | Price T Rowe Associates | Reduced | -1.02M sh | $685.82M | +2.9% | +2.1% | — | ||||
| 13F | Price T Rowe Associates | Reduced | -1.02M sh | $651.17M | +2.9% | +2.1% | — | ||||
| 13F | Marshall Wace | Reduced | -265.39K sh | $240.28M | +2.9% | +2.1% | — | ||||
| 13F | Marshall Wace | Reduced | -265.39K sh | $233.96M | +2.9% | +2.1% | — | ||||
| 13F | Manufacturers Life Insurance Company, the | Reduced | -1.66M sh | $207.50M | +2.9% | +2.1% | — | ||||
| 13F | Manufacturers Life Insurance Company, the | Reduced | -1.66M sh | $202.04M | +2.9% | +2.1% | — | ||||
| 13F | Mai Capital Management | Reduced | -6.80K sh | $4.06M | +2.9% | +2.1% | — | ||||
| 13F | Jones Financial Companies | Added | +282.87K sh | $56.96M | +2.9% | +2.1% | — | ||||
| 13F | Jones Financial Companies | Added | +282.87K sh | $55.47M | +2.9% | +2.1% | — | ||||
| 13F | Focus Partners Wealth | Reduced | -175.05K sh | $143.68M | +2.9% | +2.1% | — | ||||
| 13F | Focus Partners Wealth | Reduced | -175.05K sh | $139.90M | +2.9% | +2.1% | — | ||||
| 13F | Charles Schwab Investment Management | Reduced | -745.51K sh | $515.87M | +2.9% | +2.1% | — | ||||
| 13F | Charles Schwab Investment Management | Reduced | -745.51K sh | $489.81M | +2.9% | +2.1% | — | ||||
| 13F | Cerity Partners | Reduced | -43.55K sh | $35.08M | +2.9% | +2.1% | — | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +0.5% | -2.8% | +20.5% | — |
Showing 32 of 102 filings (the latest 13F moves are capped at 25; see the institutions below).
1W / 1M / 6M = how BDX moved from the trade or filing date.
Insider trading in BDX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Feld Michael | EVP, Chief Revenue Officer | 1 | -$13.96K | Sep 28, 2026 | |
| Michael Feld | EVP, Chief Revenue Officer | 1 | -$11.46K | Jun 26, 2026 | |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 1 | -$160.23K | Jun 24, 2026 |
Members of Congress trading BDX
Institutions moving BDX (13F)
- Wellington Management Group2
- T. Rowe Price Investment Management2
- State Street2
- Price T Rowe Associates2
- Marshall Wace2
- Manufacturers Life Insurance Company, the2
- Jones Financial Companies2
- Focus Partners Wealth2
- Charles Schwab Investment Management2
- Cerity Partners2
- American Century Companies2
- Rockefeller Capital Management L.P.2
Analyst ratings on BDX
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Barclays | Reiterates | Underweight | $165 | +4.8% | — |
Frequently asked questions
Are BDX insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $185.65K, a net -$185.65K.
What is the latest insider trade in BDX?
Feld Michael, EVP, Chief Revenue Officer filed a sell (open-market sale) of 76 sh worth $13.96K on Sep 28, 2026.
Which members of Congress traded BDX?
3 disclosed trades by Thomas Kean, Thomas H. Kean Jr. and Alan Armstrong. The latest was on May 21, 2026.
Which institutions changed their BDX positions?
Recent 13F filers moving the stock include Wellington Management Group, T. Rowe Price Investment Management, State Street, Price T Rowe Associates and Marshall Wace.
Other medical instruments & supplies stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.